IoT-Enhanced Innovations in Drug Delivery Systems for Targeted Therapy in Autoimmune Disorders
V Bhuvaneshwari, R Sadaieswaran, P. Malathi, N Legapriyadharshini, T. Thirumalaikumari, S R Raja
Abstract
The growing number of autoimmune diseases necessitates the needs novel drug delivery system alternatives to improve targeted therapy. The study deals with the immediate requirement for improvements by investigating the limitations of existing systems, highlighting their limitations in precision, patient adherence, and real-time monitoring. The proposed system combines Internet of Things (IoT) technology into medicine distribution, providing an extensive structure that makes use of smart devices, sensors, and networking solutions. The integration attempts to improve patient participation and treatment efficacy by ensuring tailored regimens. The study demonstrates promising discoveries in optimizing therapeutic interventions, cost-effectiveness, and data-driven insights through an in-depth evaluation of case studies and successful implementations. The proposed IoT-enhanced drug delivery system not only addresses the limitations of existing systems but also represents an evolution for healthcare professionals and pharmaceutical businesses. Patient privacy and data security are essential for ethical and regulatory reasons. The study's results and analysis highlight the proposed system's potential for overcoming limitations and enhancing targeted therapy for autoimmune disorders, setting the groundwork for a future in which IoT seamlessly interacts with drug delivery systems to transform patient care.